Xponance’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$396K Sell
2025
Q2
$318K Buy
2025
Q1
$352K Buy
2024
Q4
$449K Buy
2024
Q3
$384K Sell
2024
Q2
$528K Buy
2024
Q1
$753K Sell
2023
Q4
$774K Sell
2023
Q3
$527K Sell
2023
Q2
$1.28M Buy
2023
Q1
$357K Buy
2022
Q4
$278K Buy
2022
Q3
$359K Buy
2022
Q2
$221K Buy
2021
Q3
Sell
2021
Q2
$225K Buy